LYSIS SOLUTION - ANVISA Registration 81692610284

Access comprehensive regulatory information for LYSIS SOLUTION in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 81692610284 and manufactured by VYTTRA DIAGNOSTICOS S.A.. The registration is held by VYTTRA DIAGNOSTICOS S.A. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIAGNO SOLUÇÕES EM DIAGNÓSTICO LTDA, SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81692610284
Registration Details
ANVISA Registration Number: 81692610284
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Hemolise Diff Plus
Risk Class I

Registration Details

81692610284

25351356384202368

00904728001209

Company Information

Brazil
PT: BRASIL

Dates and Status

Jul 03, 2023

VIGENTE

09/18/2025 19:00:01